TrialEuropean journal of nuclear medicine and molecular imaging2025

Efficacy of radiolabelled PD-L1-targeted nanobody in predicting and evaluating the combined immunotherapy and chemotherapy for resectable non-small cell lung cancer.

Xin Zhou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.